Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation

Gelder, van Isabelle; Tuinenburg, AE; Schoonderwoerd, BS; Tieleman, RG; Crijns, Hjgm

doi:10.1016/s0002-9149(99)00715-8

Cited by 117 publications

(65 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Among patients who underwent ECV, paroxysmal AF was less frequent and persistent AF was more common, duration of the longest previous episode and current episode were completely different. This is consistent with current guidelines and previous studies [1,3].…”

Section: Discussionsupporting

confidence: 94%

See 1 more Smart Citation

Cardioversion of Atrial Fibrillation (RHYTHM-AF) International Registry in Poland

Kiliszek

Opolski

Włodarczyk³

et al. 2014

Cardiol J.

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 94%

“…A key procedure in the rhythm control strategy is cardioversion to sinus rhythm (SR), which can be achieved through pharmacologic or electrical means. Electrical cardioversion (ECV) is proven more effective than pharmacological cardioversion (PCV) [3], but it is costly, requires presence of an anesthesiologist and can be time-consuming.…”

Section: Introductionmentioning

confidence: 99%

Cardioversion of Atrial Fibrillation (RHYTHM-AF) International Registry in Poland

Kiliszek

Opolski

Włodarczyk³

et al. 2014

Cardiol J.

View full text Add to dashboard Cite

show abstract

“…1 The rate of recurrence of AF (i.e., relapse) after conversion to sinus rhythm is high, with only about 15% of patients remaining in sinus rhythm 1 year after electrical cardioversion. 1,[11][12][13] Class I and class III antiarrhythmic agents are the primary pharmacologic agents used for achieving rhythm control in patients with AF. Patterns of use of these agents have changed in recent years.…”

Section: Rate Versus Rhythm Controlmentioning

confidence: 99%

Pharmacologic Management of Atrial Fibrillation: Established and Emerging Options

Kalus

2009

JMCP

View full text Add to dashboard Cite

BACKGROUND: In patients with atrial fibrillation (AF), antiarrhythmic drug therapy currently plays a greater role in maintaining sinus rhythm after cardioversion than it does in converting AF to sinus rhythm. Amiodarone is the most effective antiarrhythmic agent for maintaining sinus rhythm after cardioversion in patients with AF. However, its pharmacokinetics is complex; the drug interacts with many commonly used medications; and long-term use can cause thyroid dysfunction, hepatotoxicity, and other severe extracardiac adverse effects. The use of antiarrhythmic strategies in patients with AF has decreased because of evidence of greater safety and lower costs for hospitalization obtained from the use of rate-control strategies instead. Nevertheless, some patients require a rhythm-control strategy. Warfarin is used to prevent embolic stroke in many patients with AF, but its use is also complex and requires monitoring. Therefore, efforts have been made to develop antiarrhythmic agents with improved tolerability and anticoagulants that are easy to use.

show abstract

“…The observed AF relapse rate of 59%, 4 weeks after cardioversion, is consistent with previously published data. [12] and [13] In summary, the study population is likely to be representative of the clinical reality.…”

Section: Study Population and Traditional Factors Predicting Sr Maintmentioning

confidence: 99%

Noninvasive estimation of organization in atrial fibrillation as a predictor of sinus rhythm maintenance

Petersson

Sandberg

Platonov

et al. 2011

Journal of Electrocardiology

View full text Add to dashboard Cite

Previous studies indicate that the predictive value of atrial fibrillatory rate in patients undergoing cardioversion of atrial fibrillation (AF) of long duration is limited. The present study investigates signal entropy in this setting. Standard 12-lead electrocardiograms (ECGs) were recorded from 66 consecutive patients with AF undergoing cardioversion and sample entropy estimated. Patients were followed for 4 weeks. At follow-up, 59% of the patients had relapsed to AF. The AF signal entropy of these patients before cardioversion was 0.099 ± 0.015, whereas it was 0.093 ± 0.012 among the 41% maintaining sinus rhythm (P = .02). As hypothesized, signal entropy was lower in patients who maintained sinus rhythm 4 weeks after cardioversion than in those who did not. However, the overlap was large, making its clinical value limited.

show abstract

Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation

Cited by 117 publications

References 32 publications

Cardioversion of Atrial Fibrillation (RHYTHM-AF) International Registry in Poland

Cardioversion of Atrial Fibrillation (RHYTHM-AF) International Registry in Poland

Pharmacologic Management of Atrial Fibrillation: Established and Emerging Options

Noninvasive estimation of organization in atrial fibrillation as a predictor of sinus rhythm maintenance

Contact Info

Product

Resources

About